The report "Quantum Computing in Healthcare Market by Component (Hardware, Software), Deployment (On-premises, Cloud-based), Technology (Superconducting Qubits, Trapped Ions), Application (Drug Discovery, Genomics), End User, and Region - Global Forecast to 2030",global quantum computing in healthcare market is projected to reach USD 1,324.2 million by 2030 from USD 265.9 million in 2025, at a high CAGR of 37.9% during the forecast period.
Browse 248 market data Tables and 52 Figures spread through 293 Pages and in-depth TOC on "Quantum Computing in Healthcare Market by Component (Hardware, Software), Deployment (On-premises, Cloud-based), Technology (Superconducting Qubits, Trapped Ions), Application (Drug Discovery, Genomics), End User, and Region - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/quantum-computing-in-healthcare-market-41524710.html
The quantum computing in healthcare market is progressing steadily, driven by increasing investments in quantum-focused startups and the urgent need to streamline drug development processes. Quantum computing provides unique advantages in analyzing complex biological data, allowing for faster and more precise simulations of molecular interactions and potential therapies. This capability helps reduce both the time and financial costs associated with drug discovery, making it an invaluable tool for pharmaceutical research. As healthcare organizations strive to innovate in response to growing research and development demands, the emergence of accessible, cloud-based quantum platforms makes these technologies more applicable in real-world clinical and research environments. This shift positions quantum computing as a key enabler of next-generation advancements in personalized and efficient healthcare solutions.
“The drug discovery & development segment accounted for the largest share of the quantum computing in healthcare market, by application, in 2024.”
Drug discovery & development is the largest application segment for quantum computing in healthcare. This growth is driven by the pressing need to improve the efficiency and effectiveness of research and development efforts. Quantum computing enables advanced modeling of molecular structures, simulating drug interactions, and accelerating the screening of potential compounds—all processes that are typically resource-intensive for classical computing systems. These capabilities help reduce the time and cost of discovering new treatments. Furthermore, quantum tools offer detailed insights into complex biological pathways and potential therapeutic targets. As pharmaceutical and biotech organizations work to enhance R&D productivity and minimize the risk of trial failures, quantum computing plays a crucial role in advancing next-generation drug development strategies.
“The services segment is the fastest-growing segment in the quantum computing in healthcare market, by component, during the forecast period.”
The services segment is currently experiencing the fastest growth in the quantum computing market for healthcare. This growth is driven by the increasing demand for specialized expertise to support the adoption and application of quantum technologies. As healthcare institutions begin to explore the potential of quantum computing for applications such as diagnostics, genomics, and therapeutic development, there is a rising need for professional services. These services include implementation support, system integration, training, and consulting.
Such services help bridge the gap between quantum technology providers and healthcare users, ensuring smooth deployment of technology and alignment with medical research or clinical workflows. Because quantum systems often require tailored solutions and ongoing technical assistance, the services segment is becoming essential for enabling effective and scalable adoption in healthcare settings.
“North America dominated the quantum computing in healthcare market in 2024.”
In 2024, North America led the quantum computing in healthcare market. This dominance can be attributed to several factors, including a well-developed research landscape, substantial public and private funding for advanced technologies, and a robust network of startups and academic institutions focused on quantum computing. The US and Canada are at the forefront of integrating quantum computing into healthcare, particularly in areas like personalized medicine, molecular research, and genomic analysis.
Progress in this field is fueled by active collaborations between quantum technology firms, life science companies, and healthcare organizations. Additionally, supportive government policies and national initiatives aimed at promoting computational innovation are accelerating the adoption of these technologies. The region's advanced digital infrastructure and commitment to scientific advancement position it as a key player in shaping the future of quantum-driven healthcare innovations.
Key Players
The key players functioning in the quantum computing in healthcare market include Rigetti & Co, LLC (US), IBM (US), D-Wave Quantum Inc. (Canada), Microsoft (US), IonQ (US), Quantinuum, Ltd. (US & UK), Google, Inc. (US), Atos SE (France), QC Ware (California), Classiq Technologies, Inc. (US), Xanadu Quantum Technologies Inc. (Canada), Hefei Origin Quantum Computing Technology Co., Ltd. (China), Protiviti, Inc. (US), Quandela (France), Deloitte (UK), Accenture (Ireland), Amazon Web Services (AWS) (US), Fujitsu (Japan), Qnami (Switzerland), SEEQC (US), SandboxAQ (US), Pasqal (France), Qubit Pharmaceuticals (France), Polaris Quantum Biotech (US), and QSimulate (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/